Current ELISA users “will be floored by the speed and simplicity” of Lumit™ Cytokine Immunoassays Madison, WI USA. — Researchers studying immunity and inflammation now have a faster, easier alternative to traditional enzyme-linked immunosorbent assays (ELISAs) with new Promega bioluminescent assays launched today. The Lumit™ Cytokine Immunoassays can quantitatively detect released cytokines from cell culture samples […]
BD Rhapsody™ TCR/BCR Multiomic Assay speeds discovery in autoimmune disorders, immuno-oncology and infectious diseases FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, recently released the BD Rhapsody™ TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in […]
Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecaller. Summary: Latest chemistry enables 99.3% raw read accuracy at high data yields; new Kit […]
Cytosurge, a global leader in precision single cell manipulation, today announced the launch of FluidFM® CellEDIT, a CRISPR cell line engineering service based on its FluidFM® technology. Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for […]
MADISON, Wis. — Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca. The program gives researchers the unique opportunity to work on groundbreaking projects in an emerging field while collaborating with scientists at a global pharmaceutical company and […]
Funding will power a series of prospective clinical trials to validate Quanterix’ multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has partnered with the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate […]
Recently, China’s leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase […]
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN […]
Fully silent Fc-engineered antibodies accessible for therapeutic antibody development Redcar and Oxford, UK: Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, and mAbsolve, developers of a novel Fc silencing variant, today announced a licensing deal for mAbsolve’s Fc silencing technology. The agreement provides Absolute Antibody clients with easy license-free access to the new […]
MGI is pleased that the Court in the Northern District of California denied Illumina’s request to overturn the jury’s decision invalidating the ‘444 patent. The 444 patent was not set to expire until June 2023. Because the other patents Illumina asserted against MGI’s CoolMPSTM technology expire in August 2022, MGI now has the ability to commercialize […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
